Hydroxychloroquine is taken under schedule H1 of Drugs and Cosmetics rules by central government to prevent misuse and regulate sales of hydroxychloroquine. Hydroxychloroquine is anti-malarial medicine and known to have certain effects on novel corona virus infection (COVID-19) as per clinical trials.
source https://www.pharmatutor.org/pharma-news/2020/hydroxychloroquine-is-taken-under-schedule-h1
No comments:
Post a Comment